Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine ...
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned ...
The U.S. Food and Drug Administration (FDA) has approved 20 ZYN nicotine "pouch" products for sale after what it called "a ...
It’s the first time regulators have authorized sales of the products, which are the fastest-growing segment of the tobacco ...
The FDA announced it has authorized the marketing of 20 Zyn nicotine pouch products, citing their greater health benefits vs.
The decision doesn't mean that Zyn is safe, just less harmful than older alternatives. To remain on the market, companies generally must show that their products will reduce disease among adult ...
"There is no safe tobacco product ... The FDA said its move Thursday was based on studies showing that the Zyn pouches contain "substantially lower amounts" of harmful ingredients than do ...
Shares of Philip Morris International Inc. extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the marketing of 20 of the tobacco company’s Zyn nicotine ...